logo
16:01 Dec 05

Parmax Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
34.75
+0.28 (+0.81%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Parmax Pharma Ltd. Financials

Parmax Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
34.75
+0.28 (+0.81%)
16:01 Dec 05
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

13/100
Expensive Valuation

Technical

40/100
Technically Neutral

Strength

4

Weakness

7

Opportunity

0

Threats

0

-8,146.36 %

ROE %

-11.16 %

ROA %

0.00

EPS

-4.47

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
18.25 15.42 11.05 28.2 15.58
Operating Expenses +
15.69 13.17 14.43 27.95 17.89
Raw Material
6.72 5.51 7.03 21.54 11.46
Increase Decrease in Cost
-0.01 -0.02 0.02 0 0.34
Other Manufacturing Expense
3.82 3.34 3.14 2.2 0
Employee Cost
3.46 2.8 2.91 2.99 2.7
Miscellaneous Expenses
1.7 1.54 1.33 1.22 3.39
Operating Profit
2.56 2.25 -3.38 0.25 -2.31
Other Income
0.06 0.04 0.05 0.04 -0.07
Depreciation
1.93 1.88 1.71 1.03 0.73
Interest
0.39 0.37 0.62 0.59 0.87
Profit before tax and exceptio..
0.3 0.05 -5.66 -1.32 -3.98
Exceptional Items
0 0 0 -1.07 -1.07
PBT
0.3 0.05 -5.66 -2.4 -2.91
Provision for Taxation
0.16 0.15 0.12 -0.3 -0.3
Net Profit
0.14 -0.1 -5.78 -2.09 -4.72
NET Profit after MI
0 0 0 0 0
EPS
0.38 -0.28 -11.33 -5.6 -12.65
Operating Profit Margin (%)
14.03 14.59 -30.59 0.89 -14.83
Net Profit Margin (%)
0.77 -0.65 -52.31 -7.41 -30.3

Parmax Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 30.80 30.80 30.80 30.80 30.80 30.80
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 69.20 69.20 69.20 69.20 69.20 69.20
Shareholder Shares Holding %
Research 360 logo
Download Our App On: